McKesson Launches Dedicated Business to Support Cell and Gene Therapies Commercialization
McKesson has launched InspiroGene, a new business dedicated to supporting the commercialization of cell and gene therapies (CGTs). InspiroGene offers a range of services, including third-party logistics, specialty distribution, biologics pharmacy solutions, and a patient hub, all aimed at navigating the complex CGT landscape. With expertise in every stage of the CGT life cycle, InspiroGene provides manufacturers, payers, and providers with tools like financial management, logistics, and advanced data analytics to ensure patients access life-changing treatments.
McKesson Launches Dedicated Business to Support Cell and Gene Therapies Commercialization